Abbvie Inc. vs Labcorp Holdings Inc.
ABBV vs LH — side-by-side comparison from reported financials. ABBV leads 6, LH leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Labcorp Holdings Inc.
LH · Healthcare
$311.84-0.75%Solid
| Metric | ABBV | LH |
|---|---|---|
| Price | $276.43 | $311.84 |
| Market cap | $488B | $25.3B |
| Revenue (TTM) | $64.4B | $14.3B |
| Revenue growth | +1.8% | +5.5% |
| Net margin | 9.8% | 7.0% |
| Free cash flow | $18.2B | $1.16B |
| Net cash (debt) | ($56.2B) | ($4.55B) |
| 1-year price return | +19.8% | +12.3% |
| P/E | 77.4 | 25.3 |
| P/E vs own history (cheap-side %) | 23% | 51% |
| Dividend yield | 2.45% | 0.94% |
| Return on equity | 96% | 12% |
| Altman Z-score | 2.33 | 2.86 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 71,000 |
Full résumé-style profiles: ABBV CV · LH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.